|
|
| 12.37 Data as of 3:59pm ET |  -0.05 / -0.40%Today’s Change | 5.76 Today|||52-Week Range 15.67 | +91.78% Year-to-Date |
| Frontrunning: March 7 Mar 07 / Investing Channel |
| Previous close | 12.42 |
| Today’s open | 12.26 |
| Day’s range | 12.08 - 12.59 |
| Volume | 351,116 |
| Average volume (3 months) | 536,947 |
| Market cap | $194.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +26.92% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.39 |
| Today’s change | Today’s % change | |
|---|---|---|
| NYMXNymox Pharmaceutical... | -0.25 | -4.37% |
| TLOGTetraLogic Pharmaceu... | +0.03 | +0.35% |
| AMBIAmbit Biosciences Co... | 0.00 | 0.00% |
| OGXIOncoGenex Pharmaceut... | -0.73 | -5.27% |
| Last reporting date | March 11, 2014 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$8.7M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven J. Mento |
Chief Financial Officer, Secretary & SVP Charles J. Cashion |
Corporate headquarters San Diego, California |
.
